Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» The FDA cites risk info in letter over Contrave DTC ad
The FDA cites risk info in letter over Contrave DTC ad
The FDA cites risk info in letter over Contrave DTC ad
Submitted by
admin
on May 25, 2017 - 8:54am
Source:
Medical Marketing and Media
News Tags:
FDA
Contrave
drug ads
Orexigen Therapeutics
Headline:
The FDA cites risk info in letter over Contrave DTC ad
Do Not Allow Advertisers to Use My Personal information
